Fang Bian1, Roger P Simon, Yun Li, Larry David, Jolita Wainwright, Casey L Hall, Michael Frankel, An Zhou. 1. From the Department of Neurobiology (F.B., R.P.S., Y.L., A.Z.), and Clinical Research Center (J.W.), Morehouse School of Medicine, Atlanta, GA; Marcus Stroke and Neuroscience Center, Grady Memorial Hospital, Atlanta, GA (R.P.S., M.F.); Department of Biochemistry, Oregon Health Science University, Portland (L.D.); and Department of Neurology, Emory University, Atlanta, GA (C.L.H., M.F.).
Abstract
BACKGROUND AND PURPOSE: The proteome of newly synthesized proteins (nascent proteome) in peripheral blood mononuclear cells (PBMCs) can be a novel source of stroke biomarkers. Changes in the PBMC nascent proteome after stroke reflect the dynamic response-in-action not detectable in the total proteome (all existing proteins) in blood. Here, we test the application of nascent proteomics as a novel approach for stroke biomarker discovery. METHODS: The PBMC nascent proteome in human blood was determined by metabolic labeling of fresh PBMC cultures with azidohomoalanine (an azide-containing methionine surrogate), followed by mass spectrometry detection and quantification of azidohomoalanine-labeled proteins. The PBMC nascent and total proteomes were compared between patients with stroke and matched controls. RESULTS: Both PBMC nascent and total proteomes showed differences between stroke patients and controls. Results of hierarchical clustering analysis of proteomic data revealed greater changes in the nascent than in the total PBMC proteomes, supporting the usefulness of the PBMC nascent proteome as a novel source of stroke biomarkers. CONCLUSIONS: Nascent proteomes in PBMC can be a novel source for biomarker discovery in human stroke.
BACKGROUND AND PURPOSE: The proteome of newly synthesized proteins (nascent proteome) in peripheral blood mononuclear cells (PBMCs) can be a novel source of stroke biomarkers. Changes in the PBMC nascent proteome after stroke reflect the dynamic response-in-action not detectable in the total proteome (all existing proteins) in blood. Here, we test the application of nascent proteomics as a novel approach for stroke biomarker discovery. METHODS: The PBMC nascent proteome in human blood was determined by metabolic labeling of fresh PBMC cultures with azidohomoalanine (an azide-containing methionine surrogate), followed by mass spectrometry detection and quantification of azidohomoalanine-labeled proteins. The PBMC nascent and total proteomes were compared between patients with stroke and matched controls. RESULTS: Both PBMC nascent and total proteomes showed differences between strokepatients and controls. Results of hierarchical clustering analysis of proteomic data revealed greater changes in the nascent than in the total PBMC proteomes, supporting the usefulness of the PBMC nascent proteome as a novel source of stroke biomarkers. CONCLUSIONS: Nascent proteomes in PBMC can be a novel source for biomarker discovery in humanstroke.
Authors: Yingfang Tian; Boryana Stamova; Glen C Jickling; Dazhi Liu; Bradley P Ander; Cheryl Bushnell; Xinhua Zhan; Ryan R Davis; Piero Verro; William C Pevec; Nasim Hedayati; David L Dawson; Jane Khoury; Edward C Jauch; Arthur Pancioli; Joseph P Broderick; Frank R Sharp Journal: J Cereb Blood Flow Metab Date: 2011-12-14 Impact factor: 6.200
Authors: Yang Tang; Huichun Xu; XinLi Du; Lisa Lit; Wynn Walker; Aigang Lu; Ruiqiong Ran; Jeffrey P Gregg; Melinda Reilly; Art Pancioli; Jane C Khoury; Laura R Sauerbeck; Janice A Carrozzella; Judith Spilker; Joseph Clark; Kenneth R Wagner; Edward C Jauch; Dongwoo J Chang; Piero Verro; Joseph P Broderick; Frank R Sharp Journal: J Cereb Blood Flow Metab Date: 2006-01-04 Impact factor: 6.200
Authors: Martha Stapels; Chelsea Piper; Tao Yang; Minghua Li; Cheri Stowell; Zhi-gang Xiong; Julie Saugstad; Roger P Simon; Scott Geromanos; James Langridge; Jing-quan Lan; An Zhou Journal: Sci Signal Date: 2010-03-02 Impact factor: 8.192
Authors: Daniela C Dieterich; Jennifer J Lee; A James Link; Johannes Graumann; David A Tirrell; Erin M Schuman Journal: Nat Protoc Date: 2007 Impact factor: 13.491
Authors: Helena Manso; Tiago Krug; João Sobral; Isabel Albergaria; Gisela Gaspar; José M Ferro; Sofia A Oliveira; Astrid M Vicente Journal: J Cereb Blood Flow Metab Date: 2011-03-16 Impact factor: 6.200
Authors: Robert Meller; Andrea N Pearson; Jimmaline J Hardy; Casey L Hall; Dawn McGuire; Michael R Frankel; Roger P Simon Journal: Ann Clin Transl Neurol Date: 2016-01-15 Impact factor: 4.511